Navigation Links
Lilly Announces Senior Leadership Change
Date:1/30/2009

INDIANAPOLIS, Jan. 30 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) today announced that Enrique Conterno, currently senior vice president of health care professional markets for Lilly in the U.S., has been promoted to president, Lilly USA, LLC. Conterno will succeed Deirdre Connelly, who has led Lilly's U.S. operations since 2005. Connelly has resigned from the company to pursue other opportunities.

Conterno joined Lilly as a sales representative in 1992. From 1993 to 1995, he held roles as a financial analyst, marketing associate, and business development manager. In 1996, Conterno became sales and marketing director for Lilly's Peru affiliate, and in 1998 he assumed the same role for Lilly Brazil. In 2000, Conterno was named executive director of marketing for Lilly's intercontinental region (all international markets except for Europe and Japan). In 2003, Conterno became general manager of Lilly Mexico, and in 2006 he was promoted to vice president of Lilly's neuroscience business unit in the U.S. He then assumed his current role in June 2008.

Born in Lima, Peru, Conterno received a master's of business administration degree from Duke University in 1992. He also holds a bachelor's degree in mechanical engineering from Case Western Reserve University that he received in 1989.

"Enrique brings more than 16 years of proven results and strong leadership to one of the company's most important positions," said John Lechleiter, Ph.D., Lilly's chairman, president and chief executive officer. "He understands the complexities of the U.S. marketplace, he has stressed the need to accelerate the transformation that is underway at this company, and he is focused on the needs of the patients we serve. I am pleased that Enrique has accepted this challenge and am confident that he will succeed in this key leadership role. "

Conterno will report to Bryce Carmine, executive vice president of global marketing and sales. He will join the company's operations committee, and will remain a member of the senior management council. Conterno will assume his new role immediately.

Deirdre Connelly, former president of Lilly USA, LLC, has resigned from the company effective immediately to pursue other career interests.

Said Lechleiter, "We regret that Deirdre has decided to leave Lilly. Her passion for the patients we serve will be greatly missed. She has delivered strong results in every role she has held at Lilly. She has displayed a remarkable level of energy and integrity, and she has built a team and a culture that have proven to be successful. We wish her all the best in her future endeavors. Enrique Conterno, I am confident, will build further on the foundation Deirdre and her team have established."

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com.

(Logo: http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO )

C-LLY


'/>"/>
SOURCE Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Lilly Reports Fourth-Quarter and Full-Year 2008 Results
2. NFL Quarterback Jay Cutler to Help Families Affected by Diabetes by Joining Lillys Inspired by Diabetes Campaign
3. Law Firm Freedland Russo Spearheads Record-Setting Whistleblower Case Against Pharmaceutical Giant Eli Lilly -- Firm Expands Offices to Include L.A. Entertainment Branch
4. Lilly to Sponsor Martin Luther King Day I AM CHANGE Campaign as Part of Inaugural Gift to President-Elect Obama
5. Eli Lilly Pays a Record $1.4 Billion to Settle Federal and State Fraud Investigations into Illegal Zyprexa Off-Label Marketing Practices
6. Whistleblowers Complaints Lead Eli Lilly to Pay $800 Million to Settle Civil Medicaid Fraud Charges, According to Berg & Androphy
7. Eli Lilly and Company Agrees to Pay $1.415 Billion to Resolve Allegations of Off-Label Promotion of Zyprexa
8. Lilly Resolves Investigations of Past Zyprexa Marketing and Promotional Practices
9. Lilly Files Form 8-K/A Detailing Pro Forma Impact of ImClone Acquisition
10. Lilly Sets Date and Conference Call for Fourth-Quarter and Full-Year 2008 Financial Results Announcement
11. Lilly Announces Dividend Increase
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... ... PawPaws brand pet supplements owned by Whole Health Supply is ... of felines. The formula is all-natural and is made from Chinese herbs that have ... Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root Extract ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at ... on several important health care topics including advance care planning, healthcare costs and ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... "With 30 ... their specific project," said Christina Austin - CEO of Pixel Film Studios. , ... and all within Final Cut Pro X . Simply select a ProHand generator ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... A recent ... that most people are unfamiliar with. The article goes on to state that individuals ... also many of these less common operations such as calf and cheek reduction. The ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... report to their offering. ... kidney failure, it replaces the function of kidneys by removing ... thus the treatment helps to keep the patient body,s electrolytes ... Increasing number of ESRD patients & substantial healthcare expenditure ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: ... 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) assay ... sepsis or septic shock. With this clearance, Roche is ... a fully integrated solution for sepsis risk assessment and ... with bacterial infection and PCT levels in blood can ...
Breaking Medicine Technology: